350 related articles for article (PubMed ID: 24563632)
1. Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity.
Conese M; Piro D; Carbone A; Castellani S; Di Gioia S
ScientificWorldJournal; 2014; 2014():859817. PubMed ID: 24563632
[TBL] [Abstract][Full Text] [Related]
2. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
Conese M; Carbone A; Castellani S; Di Gioia S
Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine.
Frenette PS; Pinho S; Lucas D; Scheiermann C
Annu Rev Immunol; 2013; 31():285-316. PubMed ID: 23298209
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells for therapeutic applications in pulmonary medicine.
Stabler CT; Lecht S; Lazarovici P; Lelkes PI
Br Med Bull; 2015 Sep; 115(1):45-56. PubMed ID: 26063231
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.
Bari E; Ferrarotti I; Torre ML; Corsico AG; Perteghella S
J Control Release; 2019 Sep; 309():11-24. PubMed ID: 31326462
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem/progenitor cells express functional mitochondrial energy-dependent cystic fibrosis transmembrane conductance regulator.
Piro D; Piccoli C; Guerra L; Sassone F; D'Aprile A; Favia M; Castellani S; Di Gioia S; Lepore S; Garavaglia ML; Trotta T; Maffione AB; Casavola V; Meyer G; Capitanio N; Conese M
Stem Cells Dev; 2012 Mar; 21(4):634-46. PubMed ID: 21561312
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell trials for pulmonary diseases.
Antunes MA; Laffey JG; Pelosi P; Rocco PR
J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.
Inamdar AC; Inamdar AA
Exp Lung Res; 2013 Oct; 39(8):315-27. PubMed ID: 23992090
[TBL] [Abstract][Full Text] [Related]
9. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.
Ikonomou L; Wagner DE; Turner L; Weiss DJ
Ann Am Thorac Soc; 2019 Jun; 16(6):657-668. PubMed ID: 30917290
[TBL] [Abstract][Full Text] [Related]
10. Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice.
Kim DH; Yoo KH; Yim YS; Choi J; Lee SH; Jung HL; Sung KW; Yang SE; Oh WI; Yang YS; Kim SH; Choi SY; Koo HH
J Korean Med Sci; 2006 Dec; 21(6):1000-4. PubMed ID: 17179676
[TBL] [Abstract][Full Text] [Related]
11. Cell therapy approaches for lung diseases: current status.
Sueblinvong V; Weiss DJ
Curr Opin Pharmacol; 2009 Jun; 9(3):268-73. PubMed ID: 19349209
[TBL] [Abstract][Full Text] [Related]
12. Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.
Weiss DJ
Ann Am Thorac Soc; 2013 Oct; 10(5):S45-97. PubMed ID: 23869446
[TBL] [Abstract][Full Text] [Related]
13. Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.
Weiss DJ
Stem Cells; 2014 Jan; 32(1):16-25. PubMed ID: 23959715
[TBL] [Abstract][Full Text] [Related]
14. Stem cells and cystic fibrosis.
Conese M; Rejman J
J Cyst Fibros; 2006 Aug; 5(3):141-3. PubMed ID: 16574502
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansions and transplantations of mouse bone marrow-derived hematopoietic stem/progenitor cells.
Wang JF; Wu YF; Harrintong J; McNiece IK
J Zhejiang Univ Sci; 2004 Feb; 5(2):157-63. PubMed ID: 14674026
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells in the treatment of chronic lung disease.
Wecht S; Rojas M
Respirology; 2016 Nov; 21(8):1366-1375. PubMed ID: 27688156
[TBL] [Abstract][Full Text] [Related]
17. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.
Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A
Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680
[TBL] [Abstract][Full Text] [Related]
18. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of cellular therapy in respiratory diseases.
Abreu SC; Antunes MA; Pelosi P; Morales MM; Rocco PR
Intensive Care Med; 2011 Sep; 37(9):1421-31. PubMed ID: 21656291
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma.
Abreu SC; Antunes MA; Xisto DG; Cruz FF; Branco VC; Bandeira E; Zola Kitoko J; de Araújo AF; Dellatorre-Texeira L; Olsen PC; Weiss DJ; Diaz BL; Morales MM; Rocco PRM
Stem Cells Transl Med; 2017 Jun; 6(6):1557-1567. PubMed ID: 28425576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
